Prostate Cancer - Results from #30

Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. March 17, 2023

Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach. March 17, 2023

Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with 177 Lu-PSMA-617. A single-center prospective observational study. March 17, 2023

The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy. March 17, 2023

MATCHING BRCA AND PROSTATE CANCER IN A PUBLIC HEALTH SYSTEM: REPORT OF THE ITALIAN SOCIETY FOR URO-ONCOLOGY (SIUrO) CONSENSUS PROJECT. March 17, 2023

Randomized phase 2 Cabazitaxel dose individualization and Neutropenia prevention Trial (CAINTA) in patients with metastatic castration-resistant prostate cancer. March 16, 2023

Radial wave therapy does not improve early recovery of erectile function after nerve-sparing radical prostatectomy: a prospective trial. March 16, 2023

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes. March 16, 2023

Are high-risk prostate cancer patients being treated equally? The impact of PSA. March 16, 2023

Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer. March 16, 2023

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. March 15, 2023

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. March 15, 2023

Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective. March 15, 2023

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. March 15, 2023

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer. March 15, 2023

Spatial patterns of prostate-specific antigen testing in asymptomatic men across Australia: a population-based cohort study, 2017-2018. March 15, 2023

Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15). March 14, 2023

Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate Cancer. March 14, 2023

PSMA-positive circulating tumor cell detection and outcomes with abiraterone or enzalutamide treatment in men with metastatic castrate resistant prostate cancer. March 14, 2023

Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. March 14, 2023

Page 2 of 1288